SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Morgan Stanley Maintains Equal-Weight on Alexion Pharmaceuticals, Raises Price Target to $120

Morgan Stanley maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Equal-Weight and raises the price target from $116 to $120.

Benzinga · 05/07/2020 11:29

Morgan Stanley maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Equal-Weight and raises the price target from $116 to $120.